stockrow
Friday 6 November 2026
Export GDRX’s income statement to Excel — free account
GoodRx Holdings, Inc.
GDRX Healthcare Health Information Services
GoodRx Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $796.9 million, up 0.57% from fiscal 2024.
- Revenue
- −1.31%
- EPS
- −25.0%
- Free cash flow
- +112.5%
- Total debt
- −0.69%
Quarter to June 2026, against a year earlier
3.49
0.00
0.00%
Follow GDRX
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 5 | 6 | 6 |
+8 more TTM periods Free account |
| 2.52% | 3.22% | 4.54% | 4.90% | ||
| 0.89% | 1.24% | 2.18% | 2.37% | ||
ROIC |
5.59% | 5.59% | 6.49% | 6.35% | |
Return on Tangible Assets |
3.59% | 4.91% | 7.44% | 8.04% | |
Average Days of Receivables |
84.66 | 107.81 | 107.98 | 92.88 | |
Free Cash Flow per Share |
0.39 | 0.28 | 0.26 | 0.30 | |
Free Cash Flow |
131.70 | 96.54 | 93.88 | 104.93 | |
Capital Expenditures |
(69.88) | (73.79) | (74.02) | (74.83) | |
| Other line items | |||||
Cash ROIC |
9.21% | 7.18% | 6.87% | 7.70% | |
Accounts Receivable Turnover |
4.23 | 4.01 | 4.18 | 4.79 | |
Accounts Payable Turnover |
4.20 | 4.32 | 3.43 | 2.55 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
45.12 | 82.34 | 122.97 | 200.37 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
(0.61) | (0.55) | (0.46) | (0.41) | |
Research and Development Expense of Revenue |
14.88% | 15.24% | 15.19% | 15.47% | |
Selling, General and Administrative Expense of Revenue |
55.11% | 55.75% | 55.91% | 57.50% | |
Share Based Compensation of Revenue |
8.80% | 9.39% | 9.62% | 9.95% | |
Interest Coverage |
1.84 | 1.87 | 2.05 | 1.91 | |
Operating CF/Net income |
12.41 | 8.29 | 5.52 | 5.66 | |
Depreciation/Fixed assets |
7.86 | 7.49 | 7.09 | 7.35 | |
Capex/Depreciation |
(0.77) | (0.84) | (0.85) | (0.90) | |
Revenue per Share |
2.31 | 2.31 | 2.24 | 2.31 | |
Operating CF per Share |
0.59 | 0.50 | 0.47 | 0.52 | |
Capex per Share |
(0.21) | (0.22) | (0.21) | (0.22) | |
Capex to Sales |
0.09 | 0.09 | 0.09 | 0.09 |
Columns are period end dates · fundamentals updated 26 Oct 2026